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Summary: Three current methods for the determination of the creatine kinase-MB activity were evaluated:
electrophoresis (Beckman Inst.), ion-exchange MB-Zyme (J. T. Baker) and ion-exchange on aca (Du Pont).
Eighty patients were selected out of three groups: acute myocardial infarction, heart and vascular surgery
patients and a number of noncardiac cases. The precision of the ion-exchange methods was comparable; CV
5.7% (aca) and CV 5.2% (MB-Zyme) for a high creatine kinase-MB pool. Electrophoresis overestimated the
creatine |kinase-MB jactivity and was less precise (CV 9.6%) and less sensitive than the ion-exchange meth-
ods. The aca (Du Pont) method was less specific than the MB-Zyme. The main source of discrepancy was
samples from certain patients in the surgery unit, which gave falsely high values by the aca method, and
showed altered mobility in electrophoresis, suggesting an atypical creatine kinase. Three macro creatine ki-
nase type I included in this study were erroneously determined äs creatine kinase-MB by both the ion-ex-
change methods.
Vergleich von drei gebräuchlichen Methoden zur Bestimmung der katalytischen Aktivität von Kreatinkinase
Zusammenfassung: Drei Methoden zur Bestimmung der katalytischen Aktivität von Kreatinkinase-MB
wurden vergleichend bewertet: die Elektrophorese (Beckman Instr.), das lonenaustauschverfahren MB-
Zyme (J. T. Baker) und das lonenaustauschverfahren auf aca (Du Pont). Aus drei Gruppen wurden achtzig
Patienten gewählt: Patienten mit akutem Myokardinfarkt, Herz- und Gefäßchirurgiepatienten und eine An-
zahl von Patienten ohne Herzkrankheiten. Die Präzision der lonenaustauschmethoden war vergleichbar: VK
5,7% (aca) und VK 5,2% (MB-Zyme) für einen hohen Kreatinkinase-MB-Anteil. Die Elektrophorese ergab
zu hohe Werte für Kreatinkinase-MB und sie war weniger präzise (VK 9,6%) und weniger empfindlich als die
lonenaustauschmethode. Die aca-Methode (Du Pont) war weniger spezifisch als das lonenaustauschver-
fahren MB-Zyme. Die wichtigste Quelle für Diskrepanzen waren Muster von einigen Patienten aus der chir-
urgischen Gruppe: für sie gab die aca-Methode zu hohe Werte, und die Elektrophorese zeigte eine veränderte
Mobilität, was eine atypische Kreatinkinase suggerierte. Drei Makro-Kreatinkinasen (Typ I), welche in dieser
Studie erwähnt werden, wurden durch beide lonenaustauschmethoden irrtümlicherweise als Kreatinkinase-
MB bestimmt.
Introduction
In the roütine laboratory, creatine kinase (EC
2.7.3.2) isoenzyme MB (CK-MB)1 can be assayed
quantitatively by a number of techniques such äs
') Enzyme: Creatine kinase (CK, EC 2.7.3.2) (ATP: creatine N-
phosphotransferase); CK-MM, creatine kinase muscle isoen-
zyme; CK-BB, creatine kinase brain isoenzyme; CK-MB,
creatine kinase heart isoenzyme.
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ion-exchange Chromatographie methods (1—2) and
electrophoresis (3). We compared the results of
three of these methods: the Du Pont aca and J. T.
Baker MB-Zyme ion-exchange chromatography,
and the electrophoresis by Beckman Instr. Patients
were carefully selected in order to obtain Informa-
tion on the specificity, sensitivity and efficiency (4)
of these methods in the diagnosis of acute myocar-
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dial infarction classified according to the WHO diag-
nostic criteria (5) and confirmed by our Department
of Cardiology. Random selection of patients does
not provide enough representatives of different clini-
cal cases, such äs the relatively rare macro creatine
kinase (IgG-bound creatine kinase) and atypical
forms of creatine kinase (microheterogenity). The
limitations of each method were investigated, by
comparing the resulting data with those obtained
from the combination of the other two or all three
methods. Also the analytical precision data for the
three methods were tested on two Standards with low
and high creatine kinase-MB obtained from a
number of patients of the Department of Cardiol-
ogy.
Materials and Methods
P a t i e n t s
We collected eighty samples by venipuncture from eighty selected
indoor patients.
Fifty were confirmed myocardial infarctions, three were known to
have a persistent macro creatine kinase type I (IgG-bound crea-
tine kinase) and twenty-seven had no proven myocardial infarc-
tion, from which a significant number (n = 15) came from the
vascular surgery unit. Acute myocardial infarction patients' sam-
ples were collected between 12 and 24 hours after onset.
Procedures
Determinations of creatine kinase-MB catalytic activity were car-
ried out immediately after centrifugation at 1200g of the whole
blood. If creatine kinase-MB could not be determined immediate-
ly, samples were frozen at —25 °C, sometimes for several days.
Total creatine kinase catalytic activity was determined by the
modified method of Rosalki (6) on the aca System (Du Pont In-
struments, Wilmington, DE 19898). The starting point was 0000.,
and the scale factor was 4892. Creatine kinase-MB catalytic activ-
ity was also measured with the automated column chromatogra-
phy Du Pont aca System. Quantitative isoenzyme electrophoresis
was carried out on Paragon™ CK (Beckman Instr., Inc. Brea, CA
92621) and scanned on a Microzone Densitometer (Beckman
Inst. R-112, Inc. Fullerton, CA 92634). The ion-exchange meth-
od MB-Zyme (J. T. Baker Chemicals B. V., Deventer, Holland)
was used strictly according to the procedures of the manufacturer,
on a UV-spectrophotometer (Beckman Instr., Inc. Iwine, CA
92713). Macro creatine kinases (IgG-bound creatine kinases)
were determined by a precipitation technique with Protein-A-Se-
pharose CL-4B (Pharmacia Fine Chemicals AB, Uppsala, Swed-
en) (7). To confirm these forms, activation energy was calculated
after measuring the enzyme catalytic activity at 25 °C and 37 °C
(8).
Results
Macro crea t ine kinases
The three macro creatine kinases type I migrated
with an altered mobility in creatine kinase electro-
phoresis (between the MM and MB isoenzymes), äs
reported by several other investigators (7). These
findings were confirmed from the calculated activa-
tion energies, using the Arrhenius equation, and
measuring the reaction at two different tempera-
tures. From catalytic activity measurements at 25 °C
and 37 °C, activation energies of 42—50 kJ/mol were
calculated. The nature of the macro forms was deter-
mined by binding these sera to Piotein A-Sephafose
CL-4B, which revealed the presence of enzyme-IgG
complexes. Both the ion-exchange methods falsely
indicated these macro creatine kinases äs creatine ki-
nase-MB. This phenomenon was however recog-
nized by the abnormally high (>15%) creatine kl·-
nase-MB catalytic activities for these samples, with
normal total creatine kinase values. Even in pure
heart tissue, the creatine kinase-MB fraction of total
creatine kinase, does not reach 25%, when mea-
sured with an ion-exchange method (9). Two of
these patients suffered from angina pectoris, and the
other patient had clear autoimmune deficiencies (lu-
pus erythernatosus disseminatus). We considered
macro creatine kinase type I äs a separate entity,
which can be distinguished only by an electrophoret-
ic method. We therefore exclüded these results so
that further statistical interpretations were per-
formed on a group of 77 patients. Ambiguous results
from electrophoresis were exclüded by means of a
control serum sample containing the fluorescent al-
bumin fraction (10).
Creatine kinase-MB äs myocardial infarc-
tion index
To minimize the number of false positives and nega-
tives in our laboratory in conjunction with the clini-
cal diagnosis of acute myocardial infarction by our
Department of Cardiology, we took the following
decision levels: for the ion-exchange methods, acute
myocardial infarction-positive when creatine kinase-
MB is at least 3% of total creatine kinase; for the
electrophoresis when creatine kinase-MB is at least
10%. The creatine kinase-MB distribution of our se-
lected patient group is given in table 1.
Tab. 1. Percentage distribution of creatine kinase-MB in serum
in a group of 80 patients.
Creatine kinase-MBa n %
(U/l)
0- 10
11- 20
21- 30
31- 40
41- 50
51-100
100
21
14
12
12
3
9
9
26
18
15
15
4
11
11
Data obtained äs the arithmetical mean of both ion-exchange
methods.
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Precision data
The three described methods were tested on creatine
kinase patient sera (n = 77) and on two pools; one
from a patient group with total creatine kinase cata-
lytic activity concentration of less than 200 U/l (Pool
l, low) and the other obtained from a group with
more than 200 U/l (Pool 2, high).
Precision data with respect to those pools are sum-
marized on table 2. Electrophoresis overestimated
both the low and high activity pools. The ion-ex-
change methods showed an increased precision for
the high activity measurements.
Method correlations
The correlation between the two ion-exchange
methods was good, with a coefficient pf correlation
r = 0.967 (fig. 1).
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Fig. 1. Correlation of aca Du Pont and MB-Zyme creatine ki-
nase-MB determination. N = 77; correlation coefficient
r = 0.967; regression line y = 0.99x - 3.45.
This value was obtained when determinations were
carried out immediately after thawing. In an experi-
ment to study the influence of freezing on creatine
kinase-MB catalytic activity we found that there was
no significant decrease (2.6%) in catalytic activity
after freezing (Student t-test, p < 0.01, for all meth-
ods). The correlation between the ion-exchange
methods and the electrophoresis was high (r =
0.891, mean value), äs shown in figure2 and fig-
450
400
350
2 300
f
"S 250
200
.8
s 150
100
50
50 100 150 200
Creatine k inase -MB (aca Du Pont)[U/1]
250
Fig. 2. Correlation of aca Du Pont and electrophoresis creatine
kinase-MB determination. N = 77; correlation coefficient
r = 0.893; regression line y = 3.49x - 15.93.
Tab. 2. Comparison of precision data of three methods for measuring creatine kinase-MB catalytic activity concentration in human
serum samples-.
Creatine kinase-MB Standards
Pool lb (low)
Pool 2C (high)
aca Du Pont
Mean ± SD
(U/l)
11.4 ± 1.6
30.4 ± 5.7
CV
13.9
5.7
MB-Zyme
Mean ± SD
(U/l)
11.4 ± 1.5
30.3 ± 1.6
CV
13.3
5.2
Electrophoresis
Mean ± SD
(U/l)
23.8 ± 6.7
89.0 ± 8.5
CV
28.3
9.6
8
 Based on tenfold analysis of each Standard.
b
 Pool obtained from patients with total creatine kinase catalytic activity concentration less than 200 U/l, äs determined on aca Du Pont,
c
 Pool obtained from patients with total creatine kinase catalytic activity concentration greater than 200 U/l, äs determined on aca Du
Pont.
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Fig. 3. Correlation of MB-Zyme and electrophoresis2) creatine
kinase-MB determination. N = 77; correlation coefficieht
r = 0.889; regression line y = 3.34x + 1.00.
ure3. Nevertheless the creatine kinase-MB was
overestimated by electrophoresis, most probably due
to a relative underestimation of the creatine kinase-
MM fraction. The coefficient of correlation between
Du Pont aca and electrophoresis was r = 0.891 and
between MB-Zyme and electrophoresis r = 0.889
with respective slopes of 3.49 aiid 3.34.
Reproducib i l i ty
The aca-method showed a between-assay CV of
2.8% and the MB-Zyme assay showed a CV of
3.2%, when the patient samples were measured in
series on three executive days. Electrophoresis
seemed to be less reproducible, with a between-as-
say CV of 10%.
Predict ion data
Each method sometimes gives a result that is in dis^
agreement with those of the other two methods. In
order to Interpret these findiilgs, all results were con-
sidered in relation to the clinical diagnosis of acute
myocardial infarction, independently by a team of
cardiologists. Table 3 summarizes the true positives
and true negatives when comparing a positive crea-
tine kinase-MB value of one method with a clinical
positive acute myocardial infarction diagnosis. With
this Information we calculated for each method the
sensitivity, specificity, efficiency and the predictive
values of a negative and a positive result s defined
by Galen (4), table 3.
·* · .
v-
 *. · '
2) Percentage scanning units were formally transformed to activi-
ty units, in order to give a comparable statistical analysis for
the three methods.
Tab. 3. Comparative prediction data of three methods for creatine kinase-MB in a group of 77 selected patients.
Methods
aca Du Pont
MB-Zyme
Electrophoresis
Creatine kinase total
Falsely3
negative
1
3
7
1
Falselya
positive
7
2
3
13
Sensitivityb
98
94
86
98
Specificity0
74
92
89
51
Efficiericyd
88
93
87
82
Predictive0
value of
negative
95
89
77
93
Predictivef
value of
positive
88
96
93
79
a
 correlation was made to the confirmed diagnosis of acute myocardial infarction (A.M.L) by our Department of Cardiology.
c . . . correctly classified A.M.I.'sSensitivity = y- χ 100
total A.M.I. s
Specificity = correctly classified ηοη-Α.Μ.ΙΛ
y
 total non-A.M.I.'s
Efficiency positives + true negatives
total patients
c „ .. . .
 f . true negatives 4 Λ Λc
 Predictive value of negative = s—-—ί χ 100
total negatives
°r r. Λ- . i r · . true positives .1
 Predictive value of positive = -—-^——— x 100
total positives
A.M.I. = Acute myocardial infarction
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Discussion
The clinical usefulness of the three methods is deter-
mined by their specificity, efficiency and sensitivity.
As shown in figure 2 the Du Pont aca method gave
for a number of patients (n = 4) higher values than
expected. All were patients of the Department of
Heart and Vascular Surgery and were operated upon
the day before, but no incisions into the myocardium
were made. Electrophoresis showed a slightly more
anodic mobility than normal creatine kinase-MM.
The same phenomenon was observed by Bayer et al.
(11). In some patients suffering from myositis he
found, in addition to the MB band, an additional
band in the MM area.
In our study, this band sometimes passed through
the aca column, and was consequently reported äs
falsely additional creatine kinase-MB. Perhaps this
change is caused by incision of the skeletal muscles,
but we did not observe this phenomenon in patients
with multiple traumata. A few weeks after this study
we saw a patient with hypothermia, showing the
same additional band. Here we are dealing with
creatine kinase-MM fractions bearing different sur-
face Charge, probably metastabile creatine kinase-
MM (12) or fractions with a certain resemblance to
mitochondrial creatine kinase äs described by Le-
roux et al. (13). Within a population including such
patients, the specificity of the aca Du Pont System is
therefore decreased. However, vascular surgery pa-
tients are indeed a risk group for acute myocardial
infarction. In such cases, attention must be paid to
the Interpretation of the aca creatine kinase-MB re-
sults, in order to avoid a false acute myocardial in-
farction diagnosis. The efficiency of the three meth-
ods is comparable. An excellent sensitivity is noted
for the aca Du Pont System, while the Beckman elec-
trophoresis showed a lower valüe due to the fact that
very low creatine kinase-MB values could not be de-
tected by this method. Also the predictive value of a
negative was lower for the electrophoresis for the
same reason. Electrophoresis is the best method for
detecting macro creatine kinases; the ion-exchange
methods failed to distinguish them. Macro creatine
kinases appeared more often in patients with angina
pectoris and in patients with autoimmune deficien-
cies, than in a normal population (14). This corre-
lates well with the idea of Urdal (15) that macro
creatine kinase type I can occur äs a consequence of
autoimmunity.
This study compared three current methods for
measuring creatine kinase-MB in a group of selected
patients. We studied the precision and prediction da-
ta of each method, äs well äs the predictive value for
atypical creatine kinase-MB forms and macro crea-
tine kinases.
Method correlations show that both ion-exchange
methods are comparable, with an excellent sensitivi-
ty for the Du Pont aca method. In a selected patient
group from the vascular surgery unit, this method re-
veals a low specificity. Electrophoresis is used with
. profit to investigate atypical forms and rnacro crea-
tine kinases. Furthermore, care should be taken to
avoid false diagnosis in the Interpretation of creatine
kinase-MB from patients suffering from angina pec-
toris or System deficiencies when determined with
column chromatography.
It is preferable to determine total creatine kinase äs
well äs measuring creatine kinase-MB by an ion-ex-
change method, in order to select abnormal isoen-
zyme patterns. Sera with aberrant creatine kinase-
MB/acute myocardial infarction ratios (>0.10) are
submitted to electrophoresis, in order to identify the
nature of these multiple forms.
For follow-up purposes of acute myocardial infarc-
tion and vascular surgery patients, one has to pay
attention to those high ratios. Some of them are not
due to a recidivisin of acute myocardial infarction,
but to. aberrant creatine kinase isoenzymes.
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